Custom Pharma Services Expands Manufacturing and Development Operations

September 29, 2016

The CDMO has acquired a new building to expand its high-containment manufacturing and development operations.

Custom Pharma Services, a contract development and manufacturing (CDMO) organization, announced on Sept. 20, 2016 that it has acquired a new building to expand its high-containment manufacturing and development operations.

The new facility, the Custom Pharmaceutical Innovation Centre, is co-located on the Fairway Trading Estate in Brighton, adjacent to the company’s existing packaging and warehousing operations. Acquisition of this site will allow Custom Pharma Services to increase its capacity for clinical and product development of highly potent molecules and advance its commercial manufacturing and high-containment capabilities.

Custom Pharma Services will be exhibiting at CPhI Worldwide in Barcelona, Spain, Oct. 4–6, 2016, at booth 3B48. The CDMO will showcase how it takes compounds from clinical and product development stages to commercialization. 

Source: Custom Pharma Services